265
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Modulation of oxidative stability of haemoglobin inside liposome-encapsulated haemoglobin

, , &
Pages 471-478 | Received 23 Jul 2012, Accepted 19 Nov 2012, Published online: 11 Dec 2012

References

  • Agashe H, Lagisetty P, Awasthi S, Awasthi V. Improved formulation of liposome-encapsulated hemoglobin with an anionic non-phospholipid. Colloids Surf B Biointerfaces 2010; 75: 573–83
  • Akintonwa DA. Theoretical mechanistic basis of oxidants of methaemoglobin formation. Med Hypotheses 2000; 54: 312–20
  • Alayash AI. Oxidative mechanisms of hemoglobin-based blood substitutes. Artif Cells Blood Substit Immobil Biotechnol 2001; 29: 415–25
  • Alayash AI, Ryan BA, Fratantoni JC, Cashon RE. Redox reactivity of modified hemoglobins with hydrogen peroxide and nitric oxide: Toxicological implications. Artif Cells Blood Substit Immobil Biotechnol 1994; 22: 373–86
  • Arnoldo BD, Minei JP. Potential of hemoglobin-based oxygen carriers in trauma patients. Curr Opin Crit Care 2001; 7: 431–6
  • Awasthi V. Pharmaceutical aspects of hemoglobin-based oxygen carriers. Curr Drug Deliv 2005; 2: 133–42
  • Awasthi V, Agashe H, Doblas S, Towner R. Magnetic resonance spectroscopy for evaluation of liposome-encapsulated hemoglobin as a resuscitation fluid. Artif Cells Blood Substit Immobil Biotechnol 2010; 38: 69–78
  • Awasthi VD, Garcia D, Klipper R, Goins BA, Phillips WT. Neutral and anionic liposome-encapsulated hemoglobin: Effect of post-inserted poly (ethylene glycol)-distearoylphosphatidylethanolamine on distribution and circulation kinetics. J Pharmacol Exp Ther 2004; 309: 241–48
  • Awasthi V, Yee SH, Jerabek P, Goins B, Phillips WT. Cerebral oxygen delivery by liposome-encapsulated hemoglobin: A positron-emission tomographic evaluation in a rat model of hemorrhagic shock. J Appl Physiol 2007; 103: 28–38
  • Chan WL, Tang NL, Yim CC, Lai FM, Tam MS. New features of renal lesion induced by stroma free hemoglobin. Toxicol Pathol 2000; 28: 635–42
  • Chang TM. Modified hemoglobin-based blood substitutes: Crosslinked, recombinant and encapsulated hemoglobin. Vox Sang 1998; 74(Suppl 2)233–41
  • Chang TM. Future generations of red blood cells. J Int Med 2003; 253: 527–35
  • Chang TM. Artificial cells for cell and organ replacements. Artif Organs 2004; 28: 265–70
  • Chang TM, D’agnillo F, Yu WP, Razack S. Two future generations of blood substitutes based on polyhemoglobin-SOD-catalase and nanoencapsulation. Adv Drug Deliv Rev 2000; 40: 213–18
  • Chang TM, Lister C, Nishiya T, Varma R. Immunological effects of hemoglobin, encapsulated hemoglobin, polyhemoglobin and conjugated hemoglobin using different immunization schedules. Biomater Artif Cells Immobil Biotechnol 1992; 20: 611–18
  • Chang TM, Powanda D, Yu WP. Analysis of polyethylene-glycol-polylactide nano-dimension artificial red blood cells in maintaining systemic hemoglobin levels and prevention of methemoglobin formation. Artif Cells Blood Substit Immobil Biotechnol 2003; 31: 231–47
  • Conover CD, Linberg R, Lejeune L, Nagy M, Shum KL. PEG-Hemoglobin as a resuscitation solution in the treatment of hypovolemic shock in the anesthetized rat. Artif Organs 1999; 23: 1088–98
  • Creteur J, Sibbald W, Vincent J-L. Hemoglobin solutions – Not just red blood cell substitutes. Crit Care Med 2000; 28: 3025–34
  • Dorman SC, Kenny CF, Miller L, Hirsch RE, Harrington JP. Role of redox potential of hemoglobin-based oxygen carriers on methemoglobin reduction by plasma components. Artif Cells Blood Substit Immobil Biotechnol 2002; 30: 39–51
  • Dzik WH, Corwin H, Goodnough LT, Higgins M, Kaplan H, Murphy M, Ness P, Shulman IA, Yomtovian R. Patient safety and blood transfusion: New solutions. Transfus Med Rev 2003; 17: 169–80
  • Goodnough LT. Risks of blood transfusion. Crit Care Med 2003; 31: S678–86
  • Goodnough LT, Shander A, Brecher ME. Transfusion medicine: Looking to the future. Lancet 2003; 361: 161–9
  • Gould SA, Moore EE, Hoyt DB, Ness PM, Norris EJ, Carson JL, Hides GA, Freeman IHG, Dewoskin R, Moss GS. The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable. J Am Coll Surg 2002; 195: 445–55
  • Hoffman BM, Bull C. Linearity of the hemoglobin oxidation Bohr effect. Proc Natl Acad Sci USA 1976; 73: 800–3
  • Hughes GS, Francome SF, Antal EJ, Adams WJ, Locker PK, Yancey EP, Jacobs EE. Hematologic effects of a novel hemoglobin-based oxygen carrier in normal male and female subjects. J Lab Clin Med 1995; 126: 444–51
  • Kjellstrom BT. Blood substitutes: Where do we stand today. J Int Med 2003; 253: 495–97
  • Li S, Nickels J, Palmer AF. Liposome-encapsulated actin-hemoglobin (LEAcHb) artificial blood substitutes. Biomaterials 2005; 26: 3759–69
  • Lowe KC, Ferguson E. Benefit and risk perceptions in transfusion medicine: Blood and blood substitutes. J Int Med 2003; 253: 498–507
  • Malhotra AK, Kelly ME, Miller PR, Hartman JC, Fabian TC, Proctor KG. Resuscitation with novel hemoglobin-based oxygen carrier in a Swine model of uncontrolled perioperative hemorrhage. J Trauma 2003; 54: 915–24
  • Mansouri A, Winterhalter KH. Nonequivalence of chains in hemoglobin oxidation. Biochemistry 1973; 12: 4946–9
  • Matsuoka T. Determination of methemoglobin and carboxyhemoglobin in blood by rapid colorimetry. Biol Pharm Bull 1997; 20: 1208–11
  • Ogata Y, Goto H, Kimura T, Fukui H. Development of neo red cells (NRC) with the enzymatic reduction system of methemoglobin. Art Cells Blood Subs Immob Biotechnol 1997; 25: 417–27
  • Phillips W, Klipper R, Awasthi V, Rudolph A, Cliff R, Kwasiborski V, Goins B. Polyethylene glycol-modified liposome-encapsulated hemoglobin: A long circulating red cell substitute. J Pharmacol Exp Ther 1999; 288: 665–70
  • Powanda D, Chang TMS. Cross-linked polyhemoglobin-superoxidde dismutase-catalase supplies oxygen without causing blood brain barrier disruption or brain edema in a rat model of transient global brain ischemia-reperfusion. Art Cells Blood Subs Immob. Biotechnol 2002; 30: 25–42
  • Sakai H, Hamada K, Takeoka S, Nishide H, Tsuchida E. Physical properties of hemoglobin vesicles as red cell substitutes. Biotechnol Prog 1996; 12: 119–25
  • Sakai H, Sou K, Horinouchi H, Kobayashi K, Tsuchida E. Hemoglobin-vesicle, a cellular artificial oxygen carrier that fulfils the physiological roles of the red blood cell structure. Adv Exp Med Biol 2010; 662: 433–8
  • Sakai H, Yuasa M, Onuma H, Takeoka S, Tsuchida E. Synthesis and physicochemical characterization of a series of hemoglobin-based oxygen carriers: Objective comparison between cellular and acellular types. Bioconjug Chem 2000; 11: 56–64
  • Savitsky JP, Doczi J, Black J, Arnold JD. A clinical safety trial of stroma-free hemoglobin. Clin Pharmacol Ther 1978; 23: 73–80
  • Sehegal LR, Gould SA, Rosen AL, Sehegal HL, Moss GS. Polymerized pyridoxylated hemoglobin: A red cell substitute with normal oxygen capacity. Surgery 1983; 95: 433–8
  • Silva G, Jeney V, Chora A, Larsen R, Balla J, Soares MP. Oxidized hemoglobin is an endogenous proinflammatory agonist that targets vascular endothelial cells. J Biol Chem 2009; 284: 29582–95
  • Simoni J, Simoni G, Wesson DE, Griswold JA, Feola M. A novel hemoglobin-adenosine-glutathione based blood substitute: Evaluation of its effects on human blood ex vivo. ASAIO J 2000; 46: 679–92
  • Simoni J, Villanueva-Meyer J, Simoni G, Moeller JF, Wesson DE. Control of oxidative reactions of hemoglobin in the design of blood substitutes: Role of the ascorbate-glutathione antioxidant system. Artif Organs 2009; 33: 115–26
  • Squires JE. Artificial blood. Science 2002; 295: 1002–05
  • Stowell CP. Hemoglobin-based oxygen carriers. Curr Opin Hematol 2002; 9: 537–43
  • Takeoka S, Sakai H, Kobayashi K, Tsuchida E. Evaluation of oxygen transporting capability of hemoglobin vesicles. Blood substitutes: Present and future perspectives, E Tsuchida. Elsevier Science SA, Lausanne 1998; 171–84
  • Teramura Y, Kanazawa H, Sakai H, Takeoka S, Tsuchida E. Prolonged oxygen-carrying ability of hemoglobin vesicles by coencapsulation of catalase in vivo. Bioconjug Chem 2003; 14: 1171–6
  • Uhl L. Infectious risks of blood transfusion. Curr Hematol Rep 2002; 1: 156–62
  • Vercellotti GM, Balla G, Balla J, Nath K, Eaton JW, Jacob HS. Heme and the vasculature: An oxidative hazard that induces antioxidant defenses in the endothelium. Artif Cells Blood Substit Immobil Biotechnol 1994; 22: 207–13
  • White CT, Murray AJ, Greene JR, Smith DJ, Medina F, Makovec GT, Martin EJ, Bolin RB. Toxicity of human hemoglobin solution infused into rabbits. J Lab Clin Med 1986; 108: 121–31
  • Winslow RM. Current status of blood substitute research: Towards a new paradigm. J Int Med 2003; 253: 508–17
  • Winslow RM, Chapman KW. Pilot-scale preparation of hemoglobin solutions. Meth Enzymol 1994; 231: 3–16

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.